Neuroplast

Neuroplast is a Dutch clinical-stage stem cell technology company with European orphan designation, focusing on rapidly developing projects. Neuroplast has developed autologous stem cell therapies to improve and extend the lives of patients with neurodegenerative diseases, which, in the absence of other treatment options, could place a burden on healthcare spending. The company was founded in August 2014 by Dr. Johannes Demont and neurologist Erik Wolters.